National Research CORP 8-K filings

NRC Health announced its second quarter 2026 financial and operating results, highlighting an 11% year-over-year increase in Total Recurring Contract Value (TRCV) to $151.9 million.

NRC Health's stockholders approved amendments to the company's certificate of incorporation and bylaws, primarily removing supermajority voting requirements and easing director removal.

NRC Health amended executive equity awards, eliminating repurchase rights and issuing cash bonuses, resulting in a significant expense recognition in Q2 2026.

NRC Health reported first quarter 2026 results with a 4% revenue increase to $34.8 million and a 13% rise in Total Recurring Contract Value (TRCV) to $152.1 million.

National Research Corporation officially rebrands to NRC Health and implements a declassified board structure.

NRC Health reported a significant decline in GAAP net income and revenue for both the fourth quarter and full-year 2025, despite an 8% year-over-year increase in Total Recurring Contract Value (TRCV).

NRC Health announced its third quarter 2025 financial and operating results, highlighting recurring contract value growth and increased cash flow from operations despite declines in GAAP revenue and net income.

NRC Health announces Shane Harrison, a seasoned finance leader, as its new Executive Vice President and Chief Financial Officer, effective September 25, 2025.

NRC Health announced a net loss for the second quarter of 2025, primarily due to significant non-recurring executive compensation, even as it achieved its third consecutive quarter of sequential Total Recurring Contract Value (TRCV) growth.

National Research Corporation's shareholders approved the 2025 Omnibus Incentive Plan and elected directors at the Annual Meeting held on May 7, 2025.

NRC Health reports its Q1 2025 results, highlighting sequential growth in total recurring contract value, sales force expansion, a new share repurchase program, and the upcoming CEO transition.

National Research Corporation appoints Michael D. Hays as principal financial officer and Jordan N. Freeman as chief accounting officer, while Trent Green is set to become the new CEO in June 2025.

National Research Corporation adjusts executive compensation packages, including stock grants and bonuses, following the appointment of Trent Green as CEO.

National Research Corporation (NRC Health) announced Trent Green as its new CEO, succeeding Mike Hays, effective June 1, 2025.

National Research Corporation enters into a new credit agreement providing a $30 million revolving credit facility and a $110 million delayed draw-down term loan, amending and restating its existing credit facility.

NRC Health reports a decrease in revenue and earnings per share for the fourth quarter of 2024 compared to the same period in 2023, alongside the resignation of its Chief Product Technology Officer.

National Research Corporation's Secretary, Principal Financial Officer, and Principal Accounting Officer, Linda Stacy, has announced her retirement effective December 31, 2024.

NRC Health announced a decrease in revenue and earnings per share for the third quarter of 2024, while returning capital to shareholders through dividends and stock repurchases.

National Research Corporation has appointed Helen L. Hrdy as its new Chief Operating Officer, effective October 14, 2024.

NRC Health reported a slight decrease in revenue and earnings per share for the second quarter of 2024, while also announcing an amendment to their credit agreement and a new acquisition.

National Research Corporation held its 2024 annual meeting, where shareholders elected two directors, ratified the appointment of KPMG as auditor, and approved executive compensation on an advisory basis.

National Research Corporation, now known as NRC Health, reported its first quarter 2024 financial results, including a decrease in revenue and net income compared to the same period last year, while also announcing the appointment of Linda Stacy as Principal Financial Officer.

NRC Health announced its fourth quarter and full year 2023 results, highlighting consistent revenue, increased earnings per share, and the retirement of its CFO.

National Research Corporation has announced the promotion of Helen Hrdy to Chief Customer Officer and the appointment of three other new executive officers as part of a strategic growth plan.